Trial Profile
Pharmacokinetics and Safety of Piperacillin-Tazobactam in Neonates.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Sepsis
- Focus Pharmacokinetics
- 06 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.